Urgent Recall of Blood Pressure Medication Ramipril in UK
The Medicines and Healthcare products Regulatory Agency (MHRA) has announced an urgent recall for a widely used blood pressure medication, affecting households across the United Kingdom. The recall, issued on Tuesday, April 21, 2026, specifically targets a batch of Ramipril capsules due to potential packaging errors that could pose health risks.
Details of the Recall
The recall involves Ramipril 10mg capsules manufactured by Crescent Pharma Limited. Officials have identified that some cartons labelled as containing 10mg capsules may actually hold blister strips with a lower 5mg dose. This discrepancy could lead to underdosing, potentially compromising treatment for conditions like hypertension or heart failure.
Dr Alison Cave, Chief Safety Officer at the MHRA, emphasised the importance of immediate action. "If you take Ramipril 10mg, check the packaging for batch number GR174091," she stated. "The batch number and expiry date information can be found on the outer carton. If you have received this batch, verify that the medication name on the carton matches the blister strips inside."
Steps for Patients
Patients are instructed to contact their dispensing pharmacy if they discover that a 10mg carton contains blister strips labelled as Ramipril 5mg capsules. However, if the blister strips are correctly labelled as 10mg, no further action is required. This recall highlights the critical need for vigilance in medication management, especially for chronic conditions.
Ramipril is commonly prescribed to manage high blood pressure and heart-related issues. The typical starting dose ranges from 1.25mg to 2.5mg once daily, often initiated at a low level to minimise dizziness. The maximum recommended dose is 5mg twice daily or 10mg once daily, making accurate dosing essential for effective treatment.
Health Risks and Side Effects
While serious side effects from Ramipril are rare, the NHS advises monitoring for symptoms that require immediate medical attention. Patients should call a doctor or NHS 111 if they experience:
- Yellowing of the eyes or skin
- Unusual paleness
- Fatigue, faintness, or dizziness
- Signs of bleeding, sore throat, high temperature, or increased infections
- Severe stomach pain, which may indicate pancreatitis
- Swollen ankles, blood in urine, or lack of urination, suggesting kidney problems
This recall serves as a reminder for patients to regularly review their medications and report any concerns to healthcare professionals. The MHRA continues to investigate the issue to ensure public safety and prevent similar incidents in the future.
